Aktiesnakken — November 2011
-
er i 6,78%
-
36% vækst!
-
retssagen koster dem 14 mill!
-
meget pænt ramt
-
hvis de kan fastholde væksten bare 2 kvartaler til bliver det virkeligt interessant
-
-
ALK:
Merck forventer på nuværende
tidspunkt at indsende registreringsansøgninger for begge produkter til de
amerikanske sundhedsmyndigheder, FDA, i 2013. -
(det er græs og ragweed)
-
har i hørt omskrivningen af too big to fail? too big for jail....
-
hahaha fedt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind